RFK Jr.’s testimony on measles outbreaks draws mixed partisan responses
US Health and Human Services Secretary Robert F. Kennedy Jr. testified before two Senate committees, facing questions on vaccine policy, China's threat to the US biotech industry, and the administration's direct-to-consumer drug portal, TrumpRx. Kennedy warned that China's growing role in biotech is a 'crisis' for the US, while Democrats challenged his claims about TrumpRx's drug prices.
US Health and Human Services Secretary Robert F. Kennedy Jr. appeared before the Senate Finance Committee and the Senate Health, Education, Labor, and Pensions Committee. Kennedy faced questions on various topics, including vaccine policy and the proposed HHS budget for fiscal year 2027. He warned that China's growing role in drug development and biotech is a threat to the US, citing intellectual property theft and the loss of top scientists. Kennedy said the administration is 'compressing' pathways to expedite clinical trials and drug approval, but acknowledged the US is 'losing ground' to global competition. Democratic senators challenged Kennedy's claims about TrumpRx, the administration's direct-to-consumer drug portal, saying it offers higher prices than most insurance plans.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.